This story originally ran on Oct. 21.
German antibody firm Morphosys announced this week a collaboration with Japanese pharma Daiichi Sankyo for the development of therapeutic antibodies against hospital-acquired infections.
Daiichi Sankyo becomes Morphosys's first collaborator using Morphosys' HuCAL Platinum antibody library for new drug discovery in infectious diseases.
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
You may already have institutional access!
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
